Aug. 19 at 5:41 PM
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death: Retail Doesn’t See Much Downside For Stock
$NVO $DFAX $NDVG
https://stocktwits.com/news/equity/markets/health-canada-approves-novo-ozempic-to-reduce-risk-of-kidney-function-decline-cardiovascular-death/chsgYG8RdWB